P-selectin glycoprotein ligand-1
P-selectin glycoprotein ligand-1 (PSGL-1) is a protein that in humans is encoded by the SELPLG gene. It is a type of cell adhesion molecule (CAM) that plays a crucial role in the immune system's response to injury or infection.
Structure[edit]
PSGL-1 is a membrane protein that is typically found on the surface of white blood cells, including neutrophils, monocytes, and lymphocytes. It is a high molecular weight, heavily glycosylated protein. The protein has a unique structure, with a long, extended shape that allows it to interact with other proteins on the surface of endothelial cells.
Function[edit]
The primary function of PSGL-1 is to mediate the adhesion of circulating leukocytes to endothelial cells, which is a critical step in the immune response. This is achieved through interaction with selectins, particularly P-selectin, on the surface of the endothelial cells. This interaction allows the leukocytes to roll along the endothelial surface, a process known as leukocyte rolling. This is the first step in the process of leukocyte extravasation, which allows the leukocytes to exit the bloodstream and enter the tissues where they can combat infection or injury.
Clinical significance[edit]
Alterations in the function or expression of PSGL-1 have been implicated in a number of diseases, including inflammatory diseases, autoimmune diseases, and cancer. For example, in rheumatoid arthritis, increased expression of PSGL-1 has been observed on the surface of leukocytes, which may contribute to the inflammation and tissue damage seen in this disease. In cancer, some tumor cells have been found to express PSGL-1, which may allow them to adhere to the endothelium and spread to other parts of the body, a process known as metastasis.
Research[edit]
Research is ongoing to better understand the role of PSGL-1 in health and disease, and to develop therapies that can modulate its function. For example, drugs that block the interaction between PSGL-1 and P-selectin could potentially be used to treat inflammatory diseases or prevent cancer metastasis.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian